Brief: Acumen Pharmaceuticals, Inc. Q3 Income From Operations USD -32.265 Million
Nov 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q3 operating expenses USD 32.265 million. * Q3 basic EPS USD -0.5 * Q3 net income USD -29.765 million
Nov 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q3 operating expenses USD 32.265 million. * Q3 basic EPS USD -0.5 * Q3 net income USD -29.765 million